Aro Biotherapeutics Co — Form D/A

Aro Biotherapeutics Co of PHILADELPHIA, PA, a company, filed a Form D amendment with the SEC on 2021-04-16. The offering totals $90.3M, of which $44.8M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-04-16
• Form: D/A
• Accession: 0001192482-21-000340
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $90.3M
• Amount sold: $44.8M
• Remaining: $45.5M
• Investors: 14
• Date of first sale: 2020-12-21
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-385223

Issuer

• Name: Aro Biotherapeutics Co
• CIK: 0001773305
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 3675 MARKET STREET, SUITE 200 3675 Market Street, Suite 200, PHILADELPHIA, PA, 19104
• Phone: 215-544-1175

Officers, directors & promoters (23)

Other filings by this issuer (6)

More

• CIK 1773305 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search